Page last updated: 2024-10-20

uracil and Hyperlipemia

uracil has been researched along with Hyperlipemia in 2 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Research Excerpts

ExcerptRelevanceReference
"Alogliptin treatment significantly suppressed the postprandial elevation in serum triglyceride (incremental area under the curve [AUC]; 279 ± 31 vs."2.78Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report. ( Ito, H; Kohno, K; Kusano, K; Miyoshi, T; Morita, H; Nakamura, K; Noda, Y; Oe, H; Ohno, Y; Toh, N, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kutoh, E1
Ukai, Y1
Noda, Y1
Miyoshi, T1
Oe, H1
Ohno, Y1
Nakamura, K1
Toh, N1
Kohno, K1
Morita, H1
Kusano, K1
Ito, H1

Trials

2 trials available for uracil and Hyperlipemia

ArticleYear
Alogliptin as an initial therapy in patients with newly diagnosed, drug naïve type 2 diabetes: a randomized, control trial.
    Endocrine, 2012, Volume: 41, Issue:3

    Topics: Adult; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Fat-Restricted; Dipeptidyl-Peptidase IV Inhi

2012
Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report.
    Cardiovascular diabetology, 2013, Jan-09, Volume: 12

    Topics: Adult; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hyperli

2013